Ian Gillies Sr. finds it difficult to revisit the photos he captured while his son was undergoing treatment at the Health Sciences Centre in St. John’s. Recalling the experience is sufficient for him, as he focuses on moving forward.
The ordeal began for the Gillies family in the summer of 2023 when Ian Gillies Jr., a recent College of North Atlantic graduate, started feeling fatigued beyond the norm for a 22-year-old. His energy levels plummeted to the extent that he struggled to climb stairs at home in Conception Bay South.
As time passed, Gillies Jr.’s condition deteriorated, requiring his father to transport him to the doctor in a wheelchair. Alongside constipation, he experienced bloating and sought relief in the hot tub for pain management.
By October, a turning point arose when their family physician urgently advised them to rush to the emergency room after new test results revealed significant weight gain due to fluid retention.
Medical professionals eliminated the possibilities of cancer, infections, and common autoimmune diseases. Gillies Jr. underwent draining procedures to alleviate fluid accumulation around his abdomen, with his father assisting him amidst a web of wires and tubes.
Despite the challenging ordeal, a breakthrough occurred when Dr. Steven Rowe, then a first-year internal medicine resident, identified a rare subtype of Castleman disease known as TAFRO syndrome, which matched Gillies Jr.’s symptoms.
This discovery marked the first recognized case of TAFRO in Newfoundland and Labrador. Gillies Jr. responded well to treatment with the drug siltuximab, stabilizing his condition and enabling him to return home for Christmas.
With a newfound focus on raising awareness about Castleman and TAFRO, Rowe collaborated on a case report published in the Canadian Medical Association Journal. Through further research and collaboration with experts, a groundbreaking study was conducted to differentiate between TAFRO and another rare blood disease, HLH, using a simple blood test.
The study’s findings, published in the American Journal of Hematology, highlighted the potential for expedited diagnoses and effective treatments for these life-threatening conditions. Rowe’s dedication and the collaborative efforts with medical institutions have paved the way for improved diagnostic approaches and outcomes for rare diseases.
As Gillies Jr. and his family embrace a return to normalcy, they remain grateful for the diligence and expertise that led to his recovery, emphasizing the profound impact of early and accurate diagnoses in transforming lives.
